药明康德
25-07-28 18:11 微博认证:药明康德官方微博

WuXi AppTec Achieves Strong Growth in Revenue and Profit for Q2 and H1 2025: H1 Revenue from Continuing Operations Up 24.2% YoY, and Adjusted Non-IFRS Net Profit Up 44.4% YoY, Backlog for Continuing Operations Up 37.2% YoY ​

发布于 上海